Get the tools used by (smart)2 investors.

Fair Value Uncertainty (FINBOX)

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

-
Price
Fair Value
Upside
- - -
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

Benchmarks

Hide this widget

No data available

Metric Usage

Hide this widget

No data available

Similar Metrics

Hide this widget

No data available

Search for metric or datapoint

Definition of Fair Value Uncertainty (FINBOX)

Hide this widget

No data available

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-2052.158049543509-752.158049543509469.06469703851640200400600

The chart above depicts the distribution of fair value uncertainty (finbox) for companies operating in the Healthcare sector in the Developed economic region. Over 1,870 companies were considered in this analysis, and 1,797 had meaningful values. The average fair value uncertainty (finbox) of companies in the sector is -53.76806430722616 with a standard deviation of 224.61046231089117.

Inozyme Pharma Inc's Fair Value Uncertainty (FINBOX) of -18.583663188197193 ranks in the 26.6% percentile for the sector. The following table provides additional summary stats:

Fair Value Uncertainty (FINBOX) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents1,871
Included Constituents1,797
Min-2092.084716796875
Max422.63751220703125
Median-1.7813761665707541
Mean-53.76806430722616
Standard Deviation224.61046231089117

You can find companies with similar fair value uncertainty (finbox) using this stock screener.

All rights reserved. Terms Of Use